Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is EZETIMIBE USP (PROCESS III), with a corresponding US DMF Number 27303.
Remarkably, this DMF maintains an Active status since its submission on September 27, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 21, 2014, and payment made on November 29, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II